SCHEMBL4838439

SCHEMBL4838439

COC(=O)Cc1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccc(Cl)cc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 9/20 0.44
MMP3 P08254 5/20 0.44
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PSEN1 P49768 2/20 0.41
PSEN2 P49810 2/20 0.41
APH1B Q8WW43 2/20 0.41
NCSTN Q92542 2/20 0.41
APH1A Q96BI3 2/20 0.41
PSENEN Q9NZ42 2/20 0.41
MMP1 P03956 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
ADAM17 P78536 1/20 0.41
APP P05067 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841566 0.92 MMP8 (0.45) MMP8MMP3ALDH1A1NPSR1PSEN1
SCHEMBL4842412 0.92 MAPT (0.43) MMP8MMP3ALDH1A1NPSR1PSEN1
SCHEMBL4840569 0.90 MMP8 (0.45) MMP8MMP3ALDH1A1NPSR1MMP1
SCHEMBL4837552 0.89 PSEN1 (0.36) MMP8MMP3ALDH1A1NPSR1PSEN1
SCHEMBL4843368 0.88 POLB (0.39) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4845116 0.88 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1MMP1
SCHEMBL4840886 0.88 MMP8 (0.42) MMP8MMP3ALDH1A1NPSR1MMP1
SCHEMBL4833588 0.87 MMP8 (0.41) MMP8MMP3ALDH1A1NPSR1MAPT
SCHEMBL4833217 0.87 POLB (0.39) MMP8MMP3ALDH1A1NPSR1
SCHEMBL4841819 0.87 RORC (0.41) MMP8MMP3ALDH1A1NPSR1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MMP8 3968/4885MMP3 3739/4885ALDH1A1 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.